Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia

Management of the behavioral and psychological symptoms of dementia

(2016) Elizabeth Hersch   Clinical Interventions in Aging

ADN-1184 a monoaminergic ligand with 5-HT6/7receptor antagonist activity: pharmacological profile and potential therapeutic utility

(2013) M Kołaczkowski et al.   BRITISH JOURNAL OF PHARMACOLOGY

N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease

(2013) David Olivares et al.   Current Alzheimer Research

Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances

(2013) Jana Schulze et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Use and Safety of Antipsychotics in Behavioral Disorders in Elderly People With Dementia

(2013) Pietro Gareri et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls

(2013) Jana Schulze et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The neurobiology of falls

(2012) Alfonso Fasano et al.   NEUROLOGICAL SCIENCES

Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia

(2012) Ben A. Chindo et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats

(2012) M. Horiguchi et al.   PSYCHOPHARMACOLOGY

Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity

(2011) Andreas Gravius et al.   BEHAVIOURAL PHARMACOLOGY

Transgenic Mice as a Model for Alzheimers Disease

(2011) Christina Unger Lithner et al.   Current Alzheimer Research

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder

(2011) Richard H. Weisler et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats

(2011) M. Horiguchi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties

(2011) Adrian Newman-Tancredi et al.   PSYCHOPHARMACOLOGY

Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics

(2010) Anna Wesołowska et al.   BEHAVIOURAL PHARMACOLOGY

Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats

(2010) Gregory V. Carr et al.   PSYCHOPHARMACOLOGY

Management of agitation and aggression associated with Alzheimerʼs disease: controversies and possible solutions

(2009) Clive Ballard et al.   CURRENT OPINION IN PSYCHIATRY

Strategies for pharmacotherapy of schizophrenia

(2009) J. Arnt et al.   DRUGS OF THE FUTURE

Asenapine effects in animal models of psychosis and cognitive function

(2009) Hugh M. Marston et al.   PSYCHOPHARMACOLOGY

Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats

(2007) T ENOMOTO et al.   BEHAVIOURAL BRAIN RESEARCH

Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice

(2007) Juliana V. Leite et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats

(2007) R.E. Nordquist et al.   NEUROPHARMACOLOGY

Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment–resistant depression: Involvement of 5-HT2A receptors?

(2007) Yoshihisa Kitamura et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR